Jörg Scheidle
Algemeen Directeur bij Luye Pharma (Germany) GmbH
Profiel
Jörg Scheidle is currently the Co-Managing Director at Luye Pharma (Germany) GmbH and the Director at Luye Pharma AG.
Previously, he worked as the Chief Financial Officer & Finance Director at Immatics Biotechnologies GmbH.
He holds an MBA from the University of Dayton.
Actieve functies van Jörg Scheidle
| Bedrijven | Functie | Begin |
|---|---|---|
Luye Pharma AG
 Luye Pharma AG Pharmaceuticals: MajorHealth Technology Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany. | Directeur/Bestuurslid | - |
Luye Pharma (Germany) GmbH
 Luye Pharma (Germany) GmbH MiscellaneousMiscellaneous Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany. | Algemeen Directeur | - |
Eerdere bekende functies van Jörg Scheidle
| Bedrijven | Functie | Einde |
|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Financieel Directeur/CFO | - |
Opleiding van Jörg Scheidle
| University of Dayton | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
Luye Pharma (Germany) GmbH
Luye Pharma (Germany) GmbH MiscellaneousMiscellaneous Luye Pharma (Germany) GmbH engages in the acquisition, holding, management, and sale of participating interests in companies. It also provides remunerated and related services. The company was founded on April 20, 2016 and is headquartered in Miesbach, Germany. | Miscellaneous |
Luye Pharma AG
Luye Pharma AG Pharmaceuticals: MajorHealth Technology Luye Pharma AG engages in the development and manufacture of pharmaceutical products. It specializes in transdermal therapeutic systems as well as biodegradable, subcutaneous implants. The company is headquartered in Miesbach, Germany. | Health Technology |
